Published in Medical Patent Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Pfizer.
Report 1: Pfizer said today that clinical trials examining its different cancer-fighting approaches showed activity in patients with non-small cell lung cancer (NSCLC). Data on SUTENT(R) (sunitinib malate), as well as the investigational compounds CP-751,871 and axitinib (AG-013736), were presented at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting.
Report 2: A pharmacokinetic-pharmacodynamic model may optimize drug development programs.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.